(Core Laboratories, 31.Jan.2024) — Core Laboratories Inc. (NYSE: "CLB") reported fourth quarter 2023 revenue of $128,200,000. Core's operating income was $14,600,000, with diluted earnings per share ("EPS") of $0.14, all...
(Core Laboratories, 17.Mar.2022) — Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") and Talos Energy Inc. (NYSE: "TALO") have announced a strategic alliance to provide technical evaluation and assurance...
(Core Laboratories, 21.Apr.2021) — Core Laboratories N.V. has scheduled a conference call to discuss its first quarter 2021 earnings announcement. The call will begin at 7:30 a.m. CDT / 2:30...
(Core Laboratories, 21.Apr.2021) — Core Laboratories N.V. reported continuing operations resulted in first quarter 2021 revenue of $108,400,000. Core's operating income was $11,600,000, with earnings per diluted share ("EPS") of...
(Core Lab, 22.Apr.2020) — Core Laboratories N.V. reported that continuing operations resulted in first quarter 2020 revenue of $152,400,000. The financial results for the first quarter of 2020 include a...
(Core Laboratories, 24.Jul.2019) — Core Laboratories N.V. scheduled a conference call to discuss Core's second quarter 2019 earnings announcement. The call will begin at 7:30 a.m. CDT / 2:30 p.m....
(Core Laboratories, 24.Jul.2019) — Core Laboratories N.V. reported that continuing operations resulted in second quarter 2019 revenue of $169,000,000. Second quarter 2019 revenue was impacted by a mid-quarter divestment of...